Evidence map›Paper›PMID 42452684›Full record

ArticleJournal of clinical medicine2026

Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group.

Emine Bihter Eniseler, Atike Pinar Erdogan, Mustafa Şahbazlar, Fatma Keskin Uzundere, Teoman Şakalar, Hasibe Bilge Gür, İlhan Hacıbekiroğlu, Onur Yazdan Balcık, İsmail Beypınar, Mehmet Gürdal Savsar and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Emine Bihter EniselerDepartment of Medical Oncology, Manisa Celal Bayar University, Manisa 45030, Turkey.ORCID 0000-0001-5638-1816
Atike Pinar ErdoganDepartment of Medical Oncology, Manisa Celal Bayar University, Manisa 45030, Turkey.ORCID 0000-0003-4859-7574
Mustafa ŞahbazlarDepartment of Medical Oncology, Manisa Celal Bayar University, Manisa 45030, Turkey.
Fatma Keskin UzundereDepartment of Medical Oncology, Dicle University, Diyarbakir 21280, Turkey.ORCID 0000-0002-7881-5635
Teoman ŞakalarDepartment of Medical Oncology, Kahramanmaraş Sütçü İmam University, Kahramanmaraş 46050, Turkey.
Hasibe Bilge GürDepartment of Medical Oncology, Sakarya University, Adapazari 54100, Turkey.ORCID 0000-0001-8639-3076
İlhan HacıbekiroğluDepartment of Medical Oncology, Sakarya University, Adapazari 54100, Turkey.
Onur Yazdan BalcıkDepartment of Medical Oncology, Alanya Alaaddin Keykubat Üniversitesi, Alanya 07425, Turkey.
İsmail BeypınarDepartment of Medical Oncology, Alanya Alaaddin Keykubat Üniversitesi, Alanya 07425, Turkey.ORCID 0000-0002-0853-4096
Mehmet Gürdal SavsarDepartment of Medical Oncology, Mersin Training and Research Hospital, Mersin 33000, Turkey.
Gözde PempeDepartment of Medical Oncology, Mersin Training and Research Hospital, Mersin 33000, Turkey.
Sila OksuzDepartment of Medical Oncology, Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, Istanbul 34865, Turkey.ORCID 0000-0003-4721-0585
Tuğba BaşoğluDepartment of Medical Oncology, Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, Istanbul 34865, Turkey.ORCID 0000-0002-2059-5502
Özge DemirkıranDepartment of Medical Oncology, Aydin Adnan Menderes University, Aydin 09100, Turkey.
Bilgin DemirDepartment of Medical Oncology, Aydin Adnan Menderes University, Aydin 09100, Turkey.ORCID 0000-0003-4380-9419
Bedriye Açıkgöz YıldızDepatment of Medical Oncology, Pamukkale University, Denizli 20160, Turkey.ORCID 0000-0001-7976-3358
Atike Gökçen DemirayDepatment of Medical Oncology, Pamukkale University, Denizli 20160, Turkey.
Mehmet Sinan AkarcaDepartment of Medical Oncology, Dokuz Eylül University, Izmir 35330, Turkey.ORCID 0009-0001-5513-4351
İlkay Tuğba ÜnekDepartment of Medical Oncology, Dokuz Eylül University, Izmir 35330, Turkey.ORCID 0000-0002-9124-6123
Mahmut KaraDepartment of Medical Oncology, Van Yuzuncu Yil University, Van 65090, Turkey.ORCID 0009-0002-3090-8696
Muslih UrunDepartment of Medical Oncology, Van Yuzuncu Yil University, Van 65090, Turkey.
Ahmet Cebeli GökayDepartment of Medical Oncology, Gaziantep University, Gaziantep 27310, Turkey.
Havva YeşilDepartment of Medical Oncology, Gaziantep University, Gaziantep 27310, Turkey.ORCID 0000-0002-7870-8741
Ferhat EkinciDepartment of Medical Oncology, Manisa Celal Bayar University, Manisa 45030, Turkey.ORCID 0000-0002-9317-942X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-PD-1 progressionchemotherapyimmune checkpoint inhibitorsmetastatic melanomanivolumab

Identifiers

PMID42452684
PMCPMC13363214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.